Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1628, doi. 10.1177/1352458515612244
- By:
- Publication type:
- Article
Works matching IS 13524585 AND DT 2015 AND VI 21 AND IP 13
Results: 16
1
2
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
3
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1618, doi. 10.1177/1352458515606526
- By:
- Publication type:
- Article
4
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
5
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1632, doi. 10.1177/1352458515599848
- By:
- Publication type:
- Article
6
A case of relapsing–remitting tumour-like inflammation of the central nervous system.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
7
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1626, doi. 10.1177/1352458515587598
- By:
- Publication type:
- Article
8
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1655, doi. 10.1177/1352458515573094
- By:
- Publication type:
- Article
9
Role of membrane complement regulators in neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1644, doi. 10.1177/1352458515571446
- By:
- Publication type:
- Article
10
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1713, doi. 10.1177/1352458515570768
- By:
- Publication type:
- Article
11
Sources and level of income among individuals with multiple sclerosis compared to the general population: A nationwide population-based study.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1730, doi. 10.1177/1352458515570767
- By:
- Publication type:
- Article
12
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1693, doi. 10.1177/1352458515569098
- By:
- Publication type:
- Article
13
Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1681, doi. 10.1177/1352458514568826
- By:
- Publication type:
- Article
14
Burden of risk variants correlates with phenotype of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1670, doi. 10.1177/1352458514568174
- By:
- Publication type:
- Article
15
Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1723, doi. 10.1177/1352458514568173
- By:
- Publication type:
- Article
16
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1705, doi. 10.1177/1352458514567727
- By:
- Publication type:
- Article